Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD-crossover comparative study with famotidine and low-dose lansoprazole.
Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD-crossover comparative study with famotidine and low-dose lansoprazole.
复制标题
幽门螺杆菌感染影响法莫替丁和低剂量兰索拉唑 GORD 交叉比较研究患者抗分泌治疗的症状反应。
DOI：
--
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
Kinoshita Y.
中科院分区：
文献类型：
--
作者：
Adachi K;Hashimoto T;Komazawa Y;Mihara T;K;Fujishiro H;Ishihara S;Amano Y;Hattori S;Kinoshita Y.
